Buy Celyad Stock | CYAD Stock Price & Latest News | Public.com
CYAD

Celyad

$0.00 (0.00%)Today
    Small Market Cap
    View Celyad (CYAD) stock trends here

    About CYAD

    Celyad Oncology SA is a clinical-stage biotechnology company, which focuses on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. It operates through the following segments: Cardiology and Immuno-Oncology. The Cardiology segm...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Stats

    Market Cap$101,31M
    Volume13,36k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$13.01
    1 Year Low$6.57
    Open$6.78
    High$6.79
    Low$6.06

    Buy any stock with any amount of money.

    Download the App
    Download the app